Advisory Board and Editors Genomics
Sutthirat Sitthisak
Dr. Sutthirat Sitthisak is an Associate Professor of Microbiology in the Department of Microbiology and Paraitology at Naresuan University.
Her research interests include molecular characterization of antibiotic resistance and virulence genes in Methicillin resistant Staphylococci, Acinetobacter baumannii and Morganella morganii, and molecular characterization of Acinetobacter baumannii, Stenotrophomonas maltophilia and Escherichia coli bacteriophages: applications in medicine and biocontrol.
Nikolajs Sjakste
Experience
1978 -1987; Researcher in the Cancer Cell Chemistry Laboratory, Institute of Experimental and Clinical Medicine, Riga, Latvia.
Professor of Medical Biochemistry and Medical Genetics, University of Latvia, Faculty of Medicine (since 1998). Address: Jelgavas Street 1, Riga LV1004 Latvia. Chief of the Department of Medical Biochemistry (2011).
Leading researcher (since 2011) and Head of the Biochemistry Group, Department of Medicinal Chemistry, Latvian Institute of Organic Synthesis (since 1990).
1995 and 1997 “Red position” of CNRS 1993-1998; Institut Jacques Monod, Université Paris VII, Laboratoire de Biochimie de Différentiation, Paris, France.
Education:
Degree of Doctor of Biological Sciences (Dr. habil.), 1992, Institute of Experimental Medicine, St.-Petersburg, Russia. Degree of Candidate of Biological Sciences (Ph. D.), 1984, Cancer Research Centre, Moscow, Russia. Diploma with Distinction in Medical Biophysics, graduated from the Medico-Biological faculty of the 2nd Moscow Medical Institute, Moscow, Russia, 1978.
Nikolai Slavov
I received my undergraduate education from the Massachusetts Institute of Technology (MIT) in 2004. Then, I pursued doctoral research in the Botstein laboratory at Princeton University, aiming to understand how cells coordinate their growth, gene expression, and metabolism. We discovered a simple mechanism that can account for the growth-rate dependent transcriptional responses across a wide range of growth conditions and growth rates. After defending my dissertation in 2010, I began a postdoctoral project in the van Oudenaarden laboratory at MIT, aiming to understand the Warburg effect, a hallmark of cancer cells characterized by the fermentation of glucose in the presence of enough oxygen to support respiration. This work demonstrated that aerobic glycolysis can reduce the energy demands associated with respiratory metabolism and stress survival and that, contrary to expectations and decades-long assumptions, exponential growth at a constant rate can represent not a single metabolic/physiological state but a continuum of changing states characterized by different metabolic fluxes. Following a lead from these experiments, we obtained direct evidence for differential stoichiometry among core ribosomal proteins in unperturbed wild-type cells. Our findings support the existence of ribosomes with distinct protein composition and physiological function that represent an explored layer of regulating gene expression.
Kumaravel Somasundaram
Kumar Somasundaram is a Professor at Department of Microbiology Cell Biology, Indian Institute of Science, Bangalore, India. He obtained his Veterinary Medicine degree (1985) from Madras Veterinary College, Masters in Biotechnology (1987) and Ph.D. in bacterial genetics (1993) from Madurai Kamaraj University, Madurai, India. Subsequently, he did his post-doctoral training at Northwestern University and University of Pennsylvania in Cancer Biology before moving to Indian Institute of Science (1999) as a faculty. The major focus of his laboratory is genetics of glioma, the most common primary adult cancer
Valeria Souza
Full professor at the Universidad Nacional Autónoma de México. Winner of several national conservation awards. Expert on microbial evolutionary ecology, works studying microbial mats and complex communities at Cuatro Ciénegas Coahuila, Mexico
Mikhail Spivakov
A Regulatory Genomics group leader at Babraham Institute, Cambridge UK. Interested in the logic and robustness of gene regulation, with a particular focus on computational approaches and ageing as the experimental system.
Mitchell S Stark
For the past 20 years I have been actively working in the field of melanoma and naevi genomics. I have worked and performed my PhD candidature based at the QIMR Berghofer Medical Research Institute (1999-2015) and in 2015 I relocated as a Research Fellow in the Dermatology Research Centre, The University of Queensland Diamantina Institute. Over this time I have been working towards understanding the aetiology of melanoma, studying gene dysregulation during tumour progression along with predisposition to melanoma in families with high risk for melanoma development. My research group (genomics and miRNA biomarker discovery) based within the Dermatology Research Centre (UQDI) is currently engaged in miRNA biomarker and genomics research for early detection in melanoma, skin cancer (SCC), as well as non-small cell lung cancer.
Eike Staub
TU Braunschweig & Uni Glasgow. Metagen Gesellschaft für Genomforschung mbH.
Max Planck Institute for Molecular Genetics. Altana Pharma AG. And currently Merck Healthcare KGaA
My speciality areas are Computational Biology, Systems Biology, Oncogenomics, Drug Target Identification, Biomarker Research.
Robert G Steen
Director of the Biopolymers NextGen Sequencing Facility, Department of Genetics, Harvard Medical School.
Tim Stinear
Professor Tim Stinear is a Senior NHMRC Research Fellow and molecular microbiologist in the Department of Microbiology and Immunology at the Doherty Institute for Infection and Immunity, University of Melbourne, Australia. He leads a bacterial pathogenesis research lab that focuses on using comparative and functional genomics to understand how certain bacteria evolve, spread and cause disease. In particular, his team studies pathogenic mycobacteria and hospital superbugs Staphylococcus aureus (Golden Staph) and Vancomycin Resistant Enterococci (VRE). He received his PhD in Microbiology from Monash University in 2001 followed by a 3-year postdoctoral period at the Institut Pasteur, Paris. He is a fellow of the Australian Society for Microbiology.
Monika Stoll
Professor of Genetic Epidemiology at the Medical Faculty and Director of the Leibniz-Institute for Arteriosclerosis Research at the University of Muenster, Germany. Former Associate Editor of Physiological Genomics, Academic Editor of PLoS ONE. Main research interests: Genetics of complex disease traits, in particular cardiovascular and inflammatory diseases; comparative genomics, evolutionary medicine.
Sankar Subramanian
Senior Lecturer at the University of the Sunshine Coast, Moreton Bay, Brisbane, Australia; USC Senior Research Fellow; Smithsonian Fellow; Adjunct Research Fellow (Griffith University)
Dr Sankar Subramanian is a Senior Lecturer in Genetics. Sankar joined USC as a Senior Research Fellow in March 2017. Prior to this he worked at the Australian Research Centre for Human Evolution, Griffith University. His research primarily centers around the question of, how does genetic drift influence mutations. Sankar worked on a number of research projects to investigate the interaction between drift and mutations, which include the evolution of codon usage bias in animal genomes, temporal patterns of deleterious mutations in humans and penguins, difference in the allele frequencies of polymorphisms in global human populations. Sankar has developed methods to identify and quantify deleterious mutations in human populations. Dr Subramanian is also interested in estimating rates of mutations and divergence times between species and populations. His research also focuses on studying ancient genomes to understand the past demographic history of vertebrates including ancient penguins, tuatara (a New Zealand reptile), moa (an extinct bird) and ancient humans. Furthermore, he is investigating the population history, mutational load and admixture patterns of modern and ancient Aboriginal Australians. At USC, he has started working on the conservation genomics of Australian Dingoes.